New Study on Cervical Cancer, “Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer” is now available online!

The Marchand Institute for Minimally Invasive Surgery is thrilled to announce that our newest publication “Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer” is now available online. For the first 30 days, Elsevier is offering the article free of charge to anyone who wishes to…

Laparoscopy, Laproscopy, Minimally Invasive Surgery, OBGYN, Uncategorized

FDA Issues Clarification on Black Box Warning on Power Morcellation Devices

In an official email to the Marchand Institute for Minimally Invasive Surgery, a major research institute in the field of minimally invasive gynecologic surgery and tissue morcellation, the FDA clarified it’s position on the “Black Box” warning currently placed on laparoscopic surgical power morcellation devices (LPM’s) in the United States. Because LPM’s have the potential…

Laparoscopy, Laproscopy, Minimally Invasive Surgery, OBGYN, Uncategorized

New Marchand Institute Study Shows effect of a 20% intravenous fat emulsion therapy on IVF and ICSI

Just published in the Journal of Clinical and Translational Research, The Marchand Institute’s new study on 20% intravenous fat emulsion therapy (also known as IntralipidTM), shows the effect of this medication on patients who suffer from recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) who are seeking to conceive via invitro fertilization (IVF) or…

Laparoscopy, Menopause, Minimally Invasive Surgery, Nitrous Oxide, OBGYN, Uncategorized

Largest Study Ever on COVID19 Vaccination in Pregnancy Published by Marchand Institute

Largest study in COVID19 Vaccines in Pregnancy Released – Unexpected Findings! Newly published today in Nature’s NPJ:Vaccines journal is the largest study performed thus far on the effects of COVID19 in pregnancy.  The study included data from 141,107 pregnant women, with approximately a third receiving COVID19 vaccination in pregnancy. Using the latest data the study…

Uncategorized

Marchand Institute’s Newest Paper on Hysteroscopy Appears this Month in AJOG: Global Reports

We are thrilled to announce that our latest paper on the value of hysteroscopy on asymptomatic patients prior to assisted reproduction technologies is the first paper in this quarter’s edition of AJOG: Global Reports. The full article is available online at this link: https://www.sciencedirect.com/science/article/pii/S2666577823000199?via%3Dihub

Laparoscopy, Laproscopy, Minimally Invasive Surgery, OBGYN, Uncategorized

Marchand Institute Now Accepts the “Lets Go Brandon” ($LGB) Token

In line with being on the cutting edge of technology in Minimally Invasive Surgery, our business department has informed us that we now accept an extremely popular crypto currency, the “Lets Go Brandon” Token ($LGB). We will accept the token as payment for all surgical services. Payments can be made using the QR code below,…

Crypto Related, Laparoscopy, Minimally Invasive Surgery, OBGYN, Uncategorized

JMIG

The Marchand Institute’s Paper on Laparoscopic Cerclage to be Featured in JMIG next month!

The Marchand Institute is honored that our recent work, entitled “Complications of Laparoscopic and Transabdominal Cerclage in Patients with Cervical Insufficiency: A Systematic Review and Meta-Analysis” has been accepted for publication in the Journal of Minimally Invasive Gynecologic Surgery (JMIG). The Institute is proud to be on the cutting edge of research and evidence based…

Laparoscopy, Minimally Invasive Surgery, Uncategorized